Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma

Background Cholangiocarcinoma (CHOL) is the most prevalent type of malignancy and the second most common form of primary liver cancer, resulting in high rates of morbidity and mortality. Necroptosis is a type of regulated cell death that appears to be involved in the regulation of several aspects of cancer biology, including tumorigenesis, metastasis, and cancer immunity. This study aimed to construct a necroptosis-related gene (NRG) signature to investigate the prognosis of CHOL patients using an integrated bioinformatics analysis. Methods CHOL patient data were acquired from the Gene Expression Omnibus (GEO) (GSE89748, GSE107943) and The Cancer Genome Atlas (TCGA) databases, with NRGs data from the necroptosis pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Univariate and multivariate regression analyses were performed to establish the NRG signatures. Kaplan–Meier (KM) curves were used to evaluate the prognosis of patients with CHOL. Functional enrichment analysis was performed to identify key NRG-associated biological signaling pathways. We also applied integrative multi-omics analysis to the high- and low-risk score groups. Spearman’s rank correlation was used to clarify the relationship between the NRG signature and immune infiltration. Results 65 differentially expressed (DE) NRGs were screened, five of which were selected to establish the prognostic signature of NRGS based on multivariate Cox regression analysis. We observed that low-risk patients survived significantly longer than high-risk patients. We found that patients with high-risk scores experienced higher immune cell infiltration, drug resistance, and more somatic mutations than patients with low-risk scores. We further found that sensitivities to GW843682X, mitomycin C, rapamycin, and S-trityl-L-cysteine were significantly higher in the low-risk group than in the high-risk group. Finally, we validated the expression of five NRGs in CHOL tissues using the TCGA database, HPA database and our clinical data. Conclusion These findings demonstrate that the five-NRG prognostic signature for CHOL patients is reasonably accurate and valid, and it may prove to be of considerable value for the treatment and prognosis of CHOL patients in the future.

[1]  Zhanfeng Zhang,et al.  Identification of SLAMF1 as an immune-related key gene associated with rheumatoid arthritis and verified in mice collagen-induced arthritis model , 2022, Frontiers in Immunology.

[2]  D. Xue,et al.  Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma , 2022, Frontiers in oncology.

[3]  C. Braconi,et al.  Metabolic Reprogramming in Cholangiocarcinoma. , 2022, Journal of hepatology.

[4]  Kyoung-Mee Kim,et al.  Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer , 2021, Journal for ImmunoTherapy of Cancer.

[5]  Sharan Janjuha,et al.  Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing , 2021, Nature Communications.

[6]  M. Kruhlak,et al.  ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer , 2021, Nature communications.

[7]  Guodong Yang,et al.  Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies , 2021, Frontiers in Immunology.

[8]  Marta Migocka-Patrzałek,et al.  Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease , 2021, Cells.

[9]  Z. Duan,et al.  M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis , 2021, Cell death & disease.

[10]  Huifen Wang,et al.  Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis , 2020, Frontiers in Cell and Developmental Biology.

[11]  Zhiyong Li,et al.  An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma , 2020, Clinical Cancer Research.

[12]  I. Hong,et al.  Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer , 2020, Cancers.

[13]  L. Fabris,et al.  The Tumor Microenvironment in Cholangiocarcinoma Progression , 2020, Hepatology.

[14]  Kecheng Zhang,et al.  PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer , 2020, Technology in cancer research & treatment.

[15]  L. Fabris,et al.  Necroptosis in Cholangiocarcinoma , 2020, Cells.

[16]  Chuanlu Shen,et al.  Identification and validation of immune-related lncRNA prognostic signature for breast cancer. , 2020, Genomics.

[17]  Xiaozhong Wang,et al.  Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells , 2020, Nature Communications.

[18]  Xiaozhong Wang,et al.  Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells , 2020, Nature Communications.

[19]  M. Mikuła,et al.  Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer , 2020, EMBO molecular medicine.

[20]  Eric O Long,et al.  Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ , 2019, Front. Immunol..

[21]  Jianhong Lu,et al.  Differential expression profiling of lncRNAs related to Epstein‐Barr virus infection in the epithelial cells , 2019, Journal of medical virology.

[22]  H. Putter,et al.  Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. , 2019, JAMA surgery.

[23]  K. Ahn,et al.  Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach , 2019, Hepatology International.

[24]  T. Billiar,et al.  Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis , 2019, Cell Death & Disease.

[25]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[26]  Jianlin Wu,et al.  The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming , 2019, Neoplasia.

[27]  T. Luedde,et al.  Apoptosis and necroptosis in the liver: a matter of life and death , 2018, Nature Reviews Gastroenterology & Hepatology.

[28]  R. Boellaard,et al.  Radiomics in Vulvar Cancer: First Clinical Experience Using 18F-FDG PET/CT Images , 2018, The Journal of Nuclear Medicine.

[29]  Seung Woo Park,et al.  In Vivo Study of Natural Killer (NK) Cell Cytotoxicity Against Cholangiocarcinoma in a Nude Mouse Model , 2018, In Vivo.

[30]  F. Marincola,et al.  Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA) , 2018, Journal of Immunotherapy for Cancer.

[31]  Bin Tean Teh,et al.  Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. , 2017, Cancer discovery.

[32]  H. Shu,et al.  TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses , 2017, PLoS pathogens.

[33]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[34]  Sh Zhongyang,et al.  STAT6 silencing induces hepatocellular carcinoma-derived cell apoptosis and growth inhibition by decreasing the RANKL expression. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Qiang Yu,et al.  Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells , 2017, Cell Death Discovery.

[36]  Luca Fabris,et al.  Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma , 2017, International journal of molecular sciences.

[37]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[38]  R. Lerner,et al.  Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling , 2015, Nature Communications.

[39]  A. Floreani,et al.  Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation , 2015, Oncotarget.

[40]  Jianguo Xia,et al.  NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data , 2015, Nature Protocols.

[41]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[42]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[43]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[44]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[45]  Hongen Zhang,et al.  RCircos: an R package for Circos 2D track plots , 2013, BMC Bioinformatics.

[46]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[47]  E. Y. Kim,et al.  Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5 , 2013, Molecules and cells.

[48]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[49]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[50]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Christian von Mering,et al.  STRING: a database of predicted functional associations between proteins , 2003, Nucleic Acids Res..